Clinical trial

Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study

NCT02528786

StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2015-11-19
PhasePHASE1

Study timeline

Study start (actual)2015-11-19Date precision: day
Registry last updated2018-01-02
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Sponsors & collaborators

Takedalead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.